Cell surface beta 1, 4-galactosyltransferase 1 promotes apoptosis by inhibiting epidermal growth factor receptor pathway

Molecular and Cellular Biochemistry

Volumn 291, Issue 1-2, 2006, Pages 69-76

  Li, Zejuan ^a   Zong, Hongliang ^a   Kong, Xiangfei ^a   Zhang, Si ^a   Wang, Hanzhou ^a   Sun, Qing ^a   Gu, Jianxin ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

1,4 galactosyltransferase1( 1,4GT1); Apoptosis; CycloheximideCHX; Epidermal growth factor receptor EGFR

Indexed keywords

BETA 1,4 GALACTOSYLTRANSFERASE 1; CASPASE 3; CYTOCHROME C; EPIDERMAL GROWTH FACTOR RECEPTOR; GALACTOSYLTRANSFERASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN BAD; PROTEIN BAX; PROTEIN KINASE B; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; AUTOPHOSPHORYLATION; CANCER CELL CULTURE; CELL SURFACE; CELL SURVIVAL; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVATION; ENZYME RELEASE; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MITOCHONDRION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-ASSOCIATED DEATH PROTEIN; CYCLOHEXIMIDE; DOWN-REGULATION; GALACTOSYLTRANSFERASES; HUMANS; ISOENZYMES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MODELS, BIOLOGICAL; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED;

EID: 33750918116     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-006-9198-3     Document Type: Article

References (44)

1. Hetts SW: To dieAor not to die: an overview of apoptosis and its role in disease. JAMA 279: 300-307, 1998
2. Carpenter G: Receptors for epidermal growth factor and other polypeptide mitogens. Annu Rev Biochem 56: 881-914, 1987
3. Sartor CI: Biological modifiers as potential rTdiosensitizers: targeting the epidermal growth factor receptor family. Semin Oncol 27: 15-20, 2000
4. Amado M, Almeida R, Schwientek T, Clausen H: Identification and characterization of large galactosyltransferase gene families: galactosyltransferases for all functions. Biochim Biophys Acta 1473: 35-53, 1999
5. Russo RN, Shaper NL, Shaper JH: Bovine beta 1-4-galactosyltransferase: two sets of mRNA transcripts encode two forms of the protein with different amino-terminal domains. In vitro translation experiments demonstrate that both the short and the long forms of the enzyme are type II membrane-bound glycoproteins. J Biol Chem 265: 3324-3331, 1990
6. Shaper NL, Hollis GF, Douglas JG, Kirsch IR, Shaper JH: Characterization of the full length cDNA for murine beta-1,4-galactosyltransferase. Novel features at the 5′-end predict two translational start sites at two in-frame AUGs. J Biol Chem 263: 10420-10428, 1988
7. Lopez LC, Youakim A, Evans SC, Shur BD: Evidence for a molecular distinction between Golgi and cell surface forms of beta 1,4-galactosyltransferase. J Biol Chem 266: 15984-15991, 1991
8. Evans SC, Lopez LC, Shur BD: Dominant negative mutation in cell surface beta 1,4-galactosyltransferase inhibits cell-cell and cell-matrix interactions. J Cell Biol 120: 1045-1057, 1993
9. Hathaway HJ, Evans SC, Dubois DH, Foote CI, Elder BH, Shur BD: Mutational analysis of the cytoplasmic domain of beta1, 4-galactosyltransferase I: Influence of phosphorylation on cell surface expression. J Cell Sci 116: 4319-4330, 2003
10. Miller DJ, Macek MB, Shur BD: Complementarity between sperm surface beta-1,4-galactosyltransferase and egg-coat ZP3 mediates sperm-egg binding. Nature 357: 589-593, 1992
11. Begovac PC, Shur BD: Cell surface galactosyltransferase mediates the initiation of neurite outgrowth from PC12 cells on laminin. J Cell Biol 110: 461-470, 1990
12. Runyan RB, Maxwell GD, Shur BD: Evidence for a novel enzymatic mechanism of neural crest cell migration on extracellular glycoconjugate matrices. J Cell Biol 102: 432-441, 1986
13. Bayna EM, Shaper JH, Shur BD: Temporally specific involvement of cell surface beta-1,4 galactosyltransferase during mouse embryo morula compaction. Cell 53: 145-157, 1988
14. Appeddu PA, Shur BD: Molecular analysis of cell surface beta-1, 4-galactosyltransferase function during cell migration. Proc Natl Acad Sci U.S.A 91: 2095-2099, 1994
15. Penno MB, Passaniti A, Fridman R, Hart GW, Jordan C, Kumar S, Scott AF: In vitro galactosylation of a 110-kDa glycoprotein by an endogenous cell surface galactosyltransferase correlates with the invasiveness of adrenal carcinoma cells. Proc Natl Acad Sci U.S.A 86: 6057-6061, 1989
16. Passaniti A, Hart GW: Metastasis-associated murine melanoma cell surface galactosyltransferase: Characterization of enzyme activity and identification of the major surface substrates. Cancer Res 50: 7261-7271, 1990
17. Hathaway HJ, Shur BD: Mammary gland morphogenesis is inhibited in transgenic mice that overexpress cell surface beta1, 4-galactosyltransferase. Development 122: 2859-2872, 1996
18. Steffgen K, Dufraux K, Hathaway H: Enhanced branching morphogenesis in mammary glands of mice lacking cell surface beta1, 4-galactosyltransferase. Dev Biol 244: 114-133, 2002
19. De la CL, Steffgen K, Martin A, McGee C, Hathaway H: Apoptosis and involution in the mammary gland are altered in mice lacking a novel receptor, beta1,4-Galactosyltransferase I. Dev Biol 272: 286-309, 2004
20. Tang D, Lahti JM, Grenet J, Kidd VJ: Cycloheximide-induced T-cell death is mediated by a Fas-associated death domain-dependent mechanism. J Biol Chem 274: 7245-7252, 1999
21. Zhang S, Cai M, Zhang SW, Hu Y, Gu JX: Involvement of beta 1, 4 galactosyltransferase 1 and Gal beta1->4GlcNAc groups in human hepatocarcinoma cell apoptosis. Mol Cell Biochem 243: 81-86, 2003
22. Hinton DA, Evans SC, Shur BD: Altering the expression of cell surface beta 1,4-galactosyltransferase modulates cell growth. Exp Cell Res 219: 640-649, 1995
23. Li Z, Wang H, Zong H, Sun Q, Kong X, Jiang J, Gu J: Downregulation of beta1,4-galactosyltransferase 1 inhibits CDK11(p58)-mediated apoptosis induced by cycloheximide. Biochem. Biophys Res Commun 327: 628-636, 2005
24. Nguyen TT, Hinton DA, Shur BD: Expressing murine beta 1,4-galactosyltransferase in HeLa cells produces a cell surface galactosyltransferase-dependent phenotype. J Biol Chem 269: 28000-28009, 1994
25. Youakim A, Shur BD: Effects of overexpression of beta 1, 4-galactosyltransferase on glycoprotein biosynthesis in F9 embryonal carcinoma cells. Glycobiology 3: 155-163, 1993
26. Lu Q, Shur BD: Sperm from beta 1,4-galactosyltransferase-null mice are refractory to ZP3-induced acrosome reactions and penetrate the zona pellucida poorly. Development 124: 4121-4131, 1997
27. Rojas M, Yao S, Lin YZ: Controlling epidermal growth factor (EGF)-stimulated Ras activation in intact cells by a cell-permeable peptide mimicking phosphorylated EGF receptor. J Biol Chem 271: 27456-27461, 1996
28. Danielsen AJ, Maihle NJ: The EGF/ErbB receptor family and apoptosis. Growth Factors 20: 1-15, 2002
29. Schlessinger J: Cell signaling by receptor tyrosine kinases. Cell 103: 211-225, 2000
30. Peruzzi F, Prisco M, Dews M, Salomoni P, Grassilli E, Romano G, Calabretta B, Baserga R: Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. Mol Cell Biol 19: 7203-7215, 1999
31. Shimamura A, Ballif BA, Richards SA, Blenis J: Rsk1 mediates a MEK-MAP kinase cell survival signal Curr Biol 10: 127-135, 2000
32. Gardai SJ, Hildeman DA, Frankel SK, Whitlock BB, Frasch SC, Borregaard N, Marrack P, Bratton DL, Henson PM: Phosphorylation of Bax Ser184 by Akt regulates its activity and apoptosis in neutrophils. J Biol Chem 279: 21085-21095, 2004
33. Harada H, Becknell B, Wilm M, Mann M, Huang LJ, Taylor SS, Scott JD, Korsmeyer SJ: Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A Mol Cell 3: 413-422, 1999
34. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ: Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 87: 619-628, 1996
35. Hathaway HJ: Cell surface beta1,4-galactosyltransferase function in mammary gland morphogenesis: Insights from transgenic and knockout mouse models. J Mammary Gland Biol Neoplasia 8: 421-433, 2003
36. Ettenberg SA, Keane MM, Nau MM, Frankel M, Wang LM, Pierce JH, Lipkowitz S: Cbl-b inhibits epidermal growth factor receptor signaling. Oncogene 18: 1855-1866, 1999
37. Ullrich A, Schlessinger J: Signal transduction by receptors with tyrosine kinase activity. Cell 61: 203-212, 1990
38. Wells A: EGF receptor. Int J Biochem Cell Biol 31: 637-643, 1999
39. Bishayee S: Role of conformational alteration in the epidermal growth factor receptor (EGFR) function. Biochem Pharmacol 60: 1217-1223, 2000
40. Goldstein JC, Waterhouse NJ, Juin P, Evan GI, Green DR: The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant. Nat Cell Biol 2: 156-162, 2000
41. BouilleB P, Strasser A: Bax and Bak: back-bone of T cell death. Nat Immunol 3: 893-894, 2002
42. Gross A, Jockel J, Wei MC, Korsmeyer SJ: Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J 17: 3878-3885, 1998
43. Datta SR, Katsov A, Hu L, Petros A, Fesik SW, Yaffe MB, Greenberg ME: 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol Cell 6: 41-51, 2000
44. Zhou XM, Liu Y, Payne G, Lutz RJ, Chittenden T: Growth factors inactivate the cell death promoter BAD by phosphorylation of its BH3 domain on Ser155. J Biol Chem 275: 25046-25051, 2000